HALOFENATE, SERUM-LIPIDS, AND EXERCISE PERFORMANCE IN CORONARY HEART-DISEASE

被引：0

作者：

ARONOW, WS

VANGROW, JS

NELSON, WH

PAGANO, J

PAPAGEOR.NP

KHURSHEED, M

HARDING, PR

KHEMKA, M

机构：

[1] LONG BEACH VET ADM HOSP, CARDIOL SECT MED SERV, LONG BEACH, CA 90801 USA

[2] UNIV CALIF, COLL MED, IRVINE, CA 92664 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1974年 / 15卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：67 / 72

页数：6

共 8 条

[1]

ARONOW WS, 1973, CLIN PHARMACOL THER, V14, P366

[2]

ARONOW WS, 1973, CLIN PHARMACOL THER, V14, P358

[3]

ARONOW WS, 1973, CLIN PHARMACOL THER, V14, P371

[4]

BERKOWITZ D, 1973, CLIN PHARMACOL THER, V14, P130

[5]

KESSLER G, 1967, ADV CLIN CHEM, V10, P45

[6] IMPORTANCE OF DESIGN OF AN EXERCISE PROTOCOL IN EVALUATION OF PATIENTS WITH ANGINA PECTORIS [J].

REDWOOD, DR ;

ROSING, DR ;

GOLDSTEI.RE ;

BEISER, GD ;

EPSTEIN, SE .

CIRCULATION, 1971, 43 (05) :618-&

[7]

ROBINSON S., 1938, ARBEITSPHYSIOL, V10, P251

[8]

WYBENGA DR, 1970, CLIN CHEM, V16, P980

← 1 →